18 December 1992
01 August 1988
COMMERCIAL ITEM DESCRIPTION
AZTREONAM FOR INJECTION
The General Services Administration has approved the use of this Commercial Item Description.
Shall be a sterile, non-pyrogenic Aztreonam powder for injection for intramuscular or intravenous use.
Shall contain approximately 780 mg L-arginine per g of Aztreonam within the applicable assay limits.
For Strength 1, each vial shall contain 1 g Aztreonam within the applicable assay limits.
For Strength 2, each vial shall contain 2 g Aztreonam within the applicable assay limits.
Materials used in the manufacture of the product shall be of a pharmaceutical grade.
Workmanship. The product shall be free from defects which detract from its appearance or impair its serviceability.
Unit. Package (PG).
For Size 1, shall be supplied 1 g in a vial of sufficient capacity for reconstitution. One package containing 10 vials, as specified, constitutes one unit.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business